Table 2 A-phase mean and 2SD, (mean + 2SD), and B-phase assessment points presented individually for each participant (1,2,3,4)
From: Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study
1 | 2 | 3 | 4 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A mean ± 2SD (mean + 2SD) | A mean ± 2SD (mean + 2SD) | A mean ± 2SD (mean + 2SD) | A mean ± 2SD (mean + 2SD) | |||||||||||||
B weeks | B weeks | B weeks | B weeks | |||||||||||||
8 | 10 | 12 | 14 | 8 | 10 | 12 | 14 | 8 | 10 | 12 | 14 | 8 | 10 | 12 | 14 | |
6MWT, m | 527 ± 64 (591) | 429 ± 59 (488) | 384 ± 73 (457) | 406 ± 23 (429) | ||||||||||||
510 | 543 | 484 | 537 | 455 | 392 | 423 | 450 | 390 | 390 | 394 | 407 | 421 | 424 | 390 | 420 | |
Treadmill, | 31.7 ± 5.8 (37.5) | α | 21.9 ± 0.7 (22.6) | 31.4 ± 1.5 (32.9) | ||||||||||||
ml/kg x min | 30.0 | 27.0 | 30.0 | 29.0 | 23.0 | 21.4 | 23.0 | 24.3# | 22.2 | 24.3 | 24.1 | 23.8* | 30.9 | 31.0 | 31.5 | 31.2 |
FI- 2, SF, R | 10 ± 5.4 (15.4) | 13.3 ± 4 (17.3) | 22.3 ± 4.8 (27.1) | 60 ± 0 (60) | ||||||||||||
Repetitions | 9 | 7 | 10 | 10 | 16 | 16 | 17 | 29# | 24 | 21 | 25 | 28# | 60 | 60 | 60 | 60 |
FI- 2, SF, L | 9.5 ± 2 (11.5, 7.5) ¤ | 12.3 ± 1 (13.3) | 19.5 ± 6.2 (25.7) | 60 ± 0 (60) | ||||||||||||
Repetitions | 5 | 5 | 7 | 7 | 13 | 15 | 16 | 25*# | 25 | 23 | 30 | 25# | 60 | 60 | 60 | 60 |
FI- 2 HF, R | 7.8 ± 4.1 (11.9) | 19.5 ± 1.2 (21.7) | 13.3 ± 7.2 (20.5) | 37.3 ± 25.4 (62.7) | ||||||||||||
Repetitions | 6 | 5 | 7 | 7 | 28 | 25 | 33 | 45*# | 16 | 18 | 31 | 34*# | 50 | 60 | 60 | 60# |
FI- 2, HF, L | 8.5 ± 3.9 (12.4) | 18.9 ± 4.4 (23.3) | 13.0 ± 5.4 (18.4) | 35.5 ± 21.3 (56.8) | ||||||||||||
Repetitions | 7 | 6 | 3 | 8 | 25 | 25 | 30 | 45*# | 11 | 15 | 28 | 25*# | 48 | 60 | 60 | 60*# |